INO · Inovio Pharmaceuticals, Inc.
Substantial doubt about the company's ability to continue as a going concern.
“In light of these factors, management believes that there is substantial doubt about the Company's ability to continue as a going concern beyond the late fourth quarter of 2026.”View the 10-Q filed May 13, 2026
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 3, 4 and 5. Form 4 must be filed within two business days of the trade.
| Date | Insider | Role | Type | Security | Shares |
|---|---|---|---|---|---|
| 2026-05-20 | Humeau Laurent |
Chief Scientific Officer |
Convert↑
Filing footnotes — Common Stock (Direct)
Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 18,081 restricted stock units was as follows: 6,027 shares vested on May 20, 2026; 6,027 shares will vest on May 20, 2027; 6,027 shares will vest on May 20, 2028. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. |
Common Stock
|
6,027 |
| 2026-05-20 | Weiner David B. |
Director |
Award↑
Filing footnotes — Common Stock Options (Direct)
This grant was made under the 2023 Omnibus Incentive Plan pursuant to the issuer's non-employee director compensation policy. Options to vest 100% on May 20, 2027. |
Common Stock Options
|
41,800 |
| 2026-05-20 | Shea Jacqueline Elizabeth |
Director, Chief Executive Officer |
Award↑
Filing footnotes — Common Stock Option (Direct)
The stock option grant was approved by Inovio's Board of Directors on March 4, 2026, subject to shareholder approval of the amendment and restatement of the Amended and Restated 2023 Omnibus Incentive Plan under which the stock options were granted. Inovio's shareholders approved the amendment and restatement of the Amended and Restated 2023 Omnibus Incentive Plan on May 20, 2026. The vesting schedule for the options granted on May 20, 2026 was as follows: 41,254 shares will vest on February 26, 2027; 41,253 shares will vest on February 26, 2028; 41,253 shares will vest on February 26, 2029. |
Common Stock Option
|
123,760 |
| 2026-05-20 | DANSEY ROGER D |
Director |
Award↑
Filing footnotes — Common Stock Options (Direct)
This grant was made under the 2023 Omnibus Incentive Plan pursuant to the issuer's non-employee director compensation policy. Options to vest 100% on May 20, 2027. |
Common Stock Options
|
41,800 |
| 2026-05-20 | Sumner Michael John |
Chief Medical Officer |
Convert↓
Filing footnotes — Restricted Stock Unit (Direct)
Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 28,350 restricted stock units was as follows: 9,450 shares vested on May 20, 2026; 9,450 shares will vest on May 20, 2027; 9,450 shares will vest on May 20, 2028. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. |
Restricted Stock Unit
|
9,450 |
| 2026-05-20 | Sumner Michael John |
Chief Medical Officer |
Award↑
Filing footnotes — Restricted Stock Unit (Direct)
Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the restricted stock units granted on May 20, 2026 was as follows: 12,562 shares will vest on February 26, 2027; 12,561 shares will vest on February 26, 2028; 12,561 and shares will vest on February 26, 2029. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. The restricted stock units were approved by Inovio's Board of Directors on March 4, 2026, subject to shareholder approval of the amendment and restatement of the Amended and Restated 2023 Omnibus Incentive Plan under which the restricted stock units were granted. Inovio's shareholders approved the amendment and restatement of the Amended and Restated 2023 Omnibus Incentive Plan on May 20, 2026. |
Restricted Stock Unit
|
37,684 |
| 2026-05-20 | Sumner Michael John |
Chief Medical Officer |
Award↑
Filing footnotes — Common Stock Option (Direct)
The stock option grant was approved by Inovio's Board of Directors on March 4, 2026, subject to shareholder approval of the amendment and restatement of the Amended and Restated 2023 Omnibus Incentive Plan under which the stock options were granted. Inovio's shareholders approved the amendment and restatement of the Amended and Restated 2023 Omnibus Incentive Plan on May 20, 2026. The vesting schedule for the options granted on May 20, 2026 was as follows: 15,626 shares will vest on February 26, 2027; 15,625 shares will vest on February 26, 2028; 15,625 shares will vest on February 26, 2029. |
Common Stock Option
|
46,876 |
| 2026-05-20 | Weiner David B. |
Director |
Award↑
Filing footnotes — Restricted Stock Unit (Direct)
Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units will vest 100% on May 20, 2027. This grant was made under the 2023 Omnibus Incentive Plan pursuant to the issuer's non-employee director compensation policy. |
Restricted Stock Unit
|
34,200 |
| 2026-05-20 | Zoth Lota S. |
Director |
Award↑
Filing footnotes — Common Stock Options (Direct)
This grant was made under the 2023 Omnibus Incentive Plan pursuant to the issuer's non-employee director compensation policy. Options to vest 100% on May 20, 2027. |
Common Stock Options
|
41,800 |
| 2026-05-20 | Miller Ann Calby |
Director |
Award↑
Filing footnotes — Common Stock Options (Direct)
This grant was made under the 2023 Omnibus Incentive Plan pursuant to the issuer's non-employee director compensation policy. Options to vest 100% on May 20, 2027. |
Common Stock Options
|
41,800 |
| 2026-05-20 | Shea Jacqueline Elizabeth |
Director, Chief Executive Officer |
Convert↑
Filing footnotes — Common Stock (Direct)
Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 84,888 restricted stock units was as follows: 28,296 shares vested on May 20, 2026; 28,296 shares will vest on May 20, 2027; 28,296 shares will vest on May 20, 2028. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. |
Common Stock
|
28,296 |
| 2026-05-20 | Shea Jacqueline Elizabeth |
Director, Chief Executive Officer |
Convert↓
Filing footnotes — Restricted Stock Unit (Direct)
Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 84,888 restricted stock units was as follows: 28,296 shares vested on May 20, 2026; 28,296 shares will vest on May 20, 2027; 28,296 shares will vest on May 20, 2028. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. |
Restricted Stock Unit
|
28,296 |
| 2026-05-20 | Sumner Michael John |
Chief Medical Officer |
Tax↓
Filing footnotes — Common Stock (Direct)
The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in the immediately preceding row and described in footnote (1) herein. |
Common Stock
|
2,693 |
| 2026-05-20 | Sumner Michael John |
Chief Medical Officer |
Convert↑
Filing footnotes — Common Stock (Direct)
Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 28,350 restricted stock units was as follows: 9,450 shares vested on May 20, 2026; 9,450 shares will vest on May 20, 2027; 9,450 shares will vest on May 20, 2028. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. |
Common Stock
|
9,450 |
| 2026-05-20 | Humeau Laurent |
Chief Scientific Officer |
Award↑
Filing footnotes — Restricted Stock Unit (Direct)
Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the restricted stock units granted on May 20, 2026 was as follows: 9,147 shares will vest on February 26, 2027; 9,147 shares will vest on February 26, 2028; and 9,146 shares will vest on February 26, 2029. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. The restricted stock units were approved by Inovio's Board of Directors on March 4, 2026, subject to shareholder approval of the amendment and restatement of the Amended and Restated 2023 Omnibus Incentive Plan under which the restricted stock units were granted. Inovio's shareholders approved the amendment and restatement of the Amended and Restated 2023 Omnibus Incentive Plan on May 20, 2026. |
Restricted Stock Unit
|
27,440 |
| 2026-05-20 | KIES PETER |
CFO |
Convert↑
Filing footnotes — Common Stock (Direct)
Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 26,100 restricted stock units was as follows: 8,700 shares vested on May 20, 2026; 8,700 shares will vest on May 20, 2027; 8,700 shares will vest on May 20, 2028. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. |
Common Stock
|
8,700 |
| 2026-05-20 | BENITO SIMON X |
Director |
Award↑
Filing footnotes — Common Stock Options (Direct)
This grant was made under the 2023 Omnibus Incentive Plan pursuant to the issuer's non-employee director compensation policy. Options to vest 100% on May 20, 2027. |
Common Stock Options
|
41,800 |
| 2026-05-20 | Humeau Laurent |
Chief Scientific Officer |
Convert↓
Filing footnotes — Restricted Stock Unit (Direct)
Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 18,081 restricted stock units was as follows: 6,027 shares vested on May 20, 2026; 6,027 shares will vest on May 20, 2027; 6,027 shares will vest on May 20, 2028. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. |
Restricted Stock Unit
|
6,027 |
| 2026-05-20 | KIES PETER |
CFO |
Tax↓
Filing footnotes — Common Stock (Direct)
The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in the immediately preceding row and described in footnote (1) herein. |
Common Stock
|
4,688 |
| 2026-05-20 | Shepard Jay |
Director |
Award↑
Filing footnotes — Restricted Stock Unit (Direct)
Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units will vest 100% on May 20, 2027. This grant was made under the 2023 Omnibus Incentive Plan pursuant to the issuer's non-employee director compensation policy. |
Restricted Stock Unit
|
34,200 |
| 2026-05-20 | Humeau Laurent |
Chief Scientific Officer |
Award↑
Filing footnotes — Common Stock Option (Direct)
The stock option grant was approved by Inovio's Board of Directors on March 4, 2026, subject to shareholder approval of the amendment and restatement of the Amended and Restated 2023 Omnibus Incentive Plan under which the stock options were granted. Inovio's shareholders approved the amendment and restatement of the Amended and Restated 2023 Omnibus Incentive Plan on May 20, 2026. The vesting schedule for the options granted on May 20, 2026 was as follows: 11,387 shares will vest on February 26, 2027; 11,387 shares will vest on February 26, 2028; 11,386 shares will vest on February 26, 2029. |
Common Stock Option
|
34,160 |
| 2026-05-20 | Zoth Lota S. |
Director |
Award↑
Filing footnotes — Restricted Stock Unit (Direct)
Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units will vest 100% on May 20, 2027. This grant was made under the 2023 Omnibus Incentive Plan pursuant to the issuer's non-employee director compensation policy. |
Restricted Stock Unit
|
34,200 |
| 2026-05-20 | Shea Jacqueline Elizabeth |
Director, Chief Executive Officer |
Tax↓
Filing footnotes — Common Stock (Direct)
The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in the immediately preceding row and described in footnote (1) herein. |
Common Stock
|
12,306 |
| 2026-05-20 | KIES PETER |
CFO |
Convert↓
Filing footnotes — Restricted Stock Unit (Direct)
Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 26,100 restricted stock units was as follows: 8,700 shares vested on May 20, 2026; 8,700 shares will vest on May 20, 2027; 8,700 shares will vest on May 20, 2028. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. |
Restricted Stock Unit
|
8,700 |
| 2026-05-20 | BENITO SIMON X |
Director |
Award↑
Filing footnotes — Restricted Stock Unit (Direct)
Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units will vest 100% on May 20, 2027. This grant was made under the 2023 Omnibus Incentive Plan pursuant to the issuer's non-employee director compensation policy. |
Restricted Stock Unit
|
34,200 |
| 2026-05-20 | YARNO WENDY L |
Director |
Award↑
Filing footnotes — Common Stock Options (Direct)
This grant was made under the 2023 Omnibus Incentive Plan pursuant to the issuer's non-employee director compensation policy. Options to vest 100% on May 20, 2027. |
Common Stock Options
|
41,800 |
| 2026-05-20 | KIES PETER |
CFO |
Award↑
Filing footnotes — Restricted Stock Unit (Direct)
Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the restricted stock units granted on May 20, 2026 was as follows: 10,827 shares will vest on February 26, 2027; 10,827 shares will vest on February 26, 2028; and 10,826 shares will vest on February 26, 2029. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. The restricted stock units were approved by Inovio's Board of Directors on March 4, 2026, subject to shareholder approval of the amendment and restatement of the Amended and Restated 2023 Omnibus Incentive Plan under which the restricted stock units were granted. Inovio's shareholders approved the amendment and restatement of the Amended and Restated 2023 Omnibus Incentive Plan on May 20, 2026. |
Restricted Stock Unit
|
32,480 |
| 2026-05-20 | DANSEY ROGER D |
Director |
Award↑
Filing footnotes — Restricted Stock Unit (Direct)
Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units will vest 100% on May 20, 2027. This grant was made under the 2023 Omnibus Incentive Plan pursuant to the issuer's non-employee director compensation policy. |
Restricted Stock Unit
|
34,200 |
| 2026-05-20 | Shepard Jay |
Director |
Award↑
Filing footnotes — Common Stock Options (Direct)
This grant was made under the 2023 Omnibus Incentive Plan pursuant to the issuer's non-employee director compensation policy. Options to vest 100% on May 20, 2027. |
Common Stock Options
|
41,800 |
| 2026-05-20 | Shea Jacqueline Elizabeth |
Director, Chief Executive Officer |
Award↑
Filing footnotes — Restricted Stock Unit (Direct)
Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the restricted stock units granted on May 20, 2026 was as follows: 33,414 shares will vest on February 26, 2027; 33,413 shares will vest on February 26, 2028; and 33,413 shares will vest on February 26, 2029. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. The restricted stock units were approved by Inovio's Board of Directors on March 4, 2026, subject to shareholder approval of the amendment and restatement of the Amended and Restated 2023 Omnibus Incentive Plan under which the restricted stock units were granted. Inovio's shareholders approved the amendment and restatement of the Amended and Restated 2023 Omnibus Incentive Plan on May 20, 2026. |
Restricted Stock Unit
|
100,240 |
| 2026-05-20 | Miller Ann Calby |
Director |
Award↑
Filing footnotes — Restricted Stock Unit (Direct)
Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units will vest 100% on May 20, 2027. This grant was made under the 2023 Omnibus Incentive Plan pursuant to the issuer's non-employee director compensation policy. |
Restricted Stock Unit
|
34,200 |
| 2026-05-20 | Humeau Laurent |
Chief Scientific Officer |
Tax↓
Filing footnotes — Common Stock (Direct)
The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in the immediately preceding row and described in footnote (1) herein. |
Common Stock
|
2,163 |
| 2026-05-20 | YARNO WENDY L |
Director |
Award↑
Filing footnotes — Restricted Stock Unit (Direct)
Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units will vest 100% on May 20, 2027. This grant was made under the 2023 Omnibus Incentive Plan pursuant to the issuer's non-employee director compensation policy. |
Restricted Stock Unit
|
34,200 |
| 2026-05-20 | KIES PETER |
CFO |
Award↑
Filing footnotes — Common Stock Option (Direct)
The stock option grant was approved by Inovio's Board of Directors on March 4, 2026, subject to shareholder approval of the amendment and restatement of the Amended and Restated 2023 Omnibus Incentive Plan under which the stock options were granted. Inovio's shareholders approved the amendment and restatement of the Amended and Restated 2023 Omnibus Incentive Plan on May 20, 2026. The vesting schedule for the options granted on May 20, 2026 was as follows: 13,254 shares will vest on February 26, 2027; 13,253 shares will vest on February 26, 2028; 13,253 shares will vest on February 26, 2029. |
Common Stock Option
|
39,760 |
| 2026-05-15 | Sumner Michael John |
Chief Medical Officer |
Convert↑
Filing footnotes — Common Stock (Direct)
Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 7,156 restricted stock units was as follows: 2,386 shares vested on May 15, 2024; 2,385 shares vested on May 15, 2025; and 2,385 shares vested on May 15, 2026. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. |
Common Stock
|
2,385 |
| 2026-05-15 | KIES PETER |
CFO |
Convert↑
Filing footnotes — Common Stock (Direct)
Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 14,313 restricted stock units was as follows: 4,771 shares vested on May 15, 2024; 4,771 shares vested on May 15, 2025; and 4,771 shares vested on May 15, 2026. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. |
Common Stock
|
4,771 |
| 2026-05-15 | Shea Jacqueline Elizabeth |
Director, Chief Executive Officer |
Convert↓
Filing footnotes — Restricted Stock Unit (Direct)
Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 53,233 restricted stock units was as follows: 17,745 shares vested on May 15, 2024; 17,744 shares vested on May 15, 2025; and 17,744 shares vested on May 15, 2026. Vested restricted stock units could be settled in shares of common stock, cash or a combination of both. |
Restricted Stock Unit
|
17,744 |
| 2026-05-15 | Sumner Michael John |
Chief Medical Officer |
Convert↓
Filing footnotes — Restricted Stock Unit (Direct)
Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 7,156 restricted stock units was as follows: 2,386 shares vested on May 15, 2024; 2,385 shares vested on May 15, 2025; and 2,385 shares vested on May 15, 2026. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. |
Restricted Stock Unit
|
2,385 |
| 2026-05-15 | Humeau Laurent |
Chief Scientific Officer |
Convert↓
Filing footnotes — Restricted Stock Unit (Direct)
Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 14,313 restricted stock units was as follows: 4,771 shares vested on May 15, 2024; 4,771 shares vested on May 15, 2025; and 4,771 shares vested on May 15, 2026. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. |
Restricted Stock Unit
|
4,771 |
| 2026-05-15 | Humeau Laurent |
Chief Scientific Officer |
Convert↑
Filing footnotes — Common Stock (Direct)
Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 14,313 restricted stock units was as follows: 4,771 shares vested on May 15, 2024; 4,771 shares vested on May 15, 2025; and 4,771 shares vested on May 15, 2026. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. |
Common Stock
|
4,771 |
| 2026-05-15 | KIES PETER |
CFO |
Convert↓
Filing footnotes — Restricted Stock Unit (Direct)
Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 14,313 restricted stock units was as follows: 4,771 shares vested on May 15, 2024; 4,771 shares vested on May 15, 2025; and 4,771 shares vested on May 15, 2026. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. |
Restricted Stock Unit
|
4,771 |
| 2026-05-15 | Humeau Laurent |
Chief Scientific Officer |
Tax↓
Filing footnotes — Common Stock (Direct)
The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in the immediately preceding row and described in footnote (1) herein. |
Common Stock
|
1,712 |
| 2026-05-15 | KIES PETER |
CFO |
Tax↓
Filing footnotes — Common Stock (Direct)
The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in the immediately preceding row and described in footnote (1) herein. |
Common Stock
|
2,571 |
| 2026-05-15 | Shea Jacqueline Elizabeth |
Director, Chief Executive Officer |
Convert↑
Filing footnotes — Common Stock (Direct)
Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 53,233 restricted stock units was as follows: 17,745 shares vested on May 15, 2024; 17,744 shares vested on May 15, 2025; and 17,744 shares vested on May 15, 2026. Vested restricted stock units could be settled in shares of common stock, cash or a combination of both. |
Common Stock
|
17,744 |
| 2026-05-15 | Shea Jacqueline Elizabeth |
Director, Chief Executive Officer |
Tax↓
Filing footnotes — Common Stock (Direct)
The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in the immediately preceding row and described in footnote (1) herein. |
Common Stock
|
7,717 |
| 2026-05-15 | Sumner Michael John |
Chief Medical Officer |
Tax↓
Filing footnotes — Common Stock (Direct)
The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in the immediately preceding row and described in footnote (1) herein. |
Common Stock
|
680 |
| 2026-03-31 | Sumner Michael John |
Chief Medical Officer |
Tax↓
Filing footnotes — Common Stock (Direct)
The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in the immediately preceding row and described in footnote (1) herein. |
Common Stock
|
1,223 |
| 2026-03-31 | Sumner Michael John |
Chief Medical Officer |
Convert↑
Filing footnotes — Common Stock (Direct)
Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested 100% on March 31, 2026. |
Common Stock
|
4,292 |
| 2026-03-31 | Sumner Michael John |
Chief Medical Officer |
Convert↓
Filing footnotes — Restricted Stock Unit (Direct)
Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested 100% on March 31, 2026. |
Restricted Stock Unit
|
4,292 |
| 2026-03-04 | Humeau Laurent |
Chief Scientific Officer |
Award↑
Filing footnotes — Restricted Stock Unit (Direct)
Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 21,560 restricted stock units granted on March 4, 2026 was as follows: 7,187 shares will vest on February 26, 2027; 7,187 shares will vest on February 26, 2028; and 7,186 shares will vest on February 26, 2029. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. |
Restricted Stock Unit
|
21,560 |